Northern Trust
SGMT icon

Northern Trust’s Sagimet Biosciences SGMT Stock Holding History

Northern Trust’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
468,385
+412,874
+744% +$2.81M ﹤0.01% 2810
2026
Q1 		$290K Hold
55,511
– – ﹤0.01% 3811
2025
Q4 		$329K Buy
55,511
+3,214
+6% +$23.1K ﹤0.01% 3800
2025
Q3 		$359K Hold
52,297
– – ﹤0.01% 3769
2025
Q2 		$399K Hold
52,297
– – ﹤0.01% 3722
2025
Q1 		$170K Buy
52,297
+11,439
+28% +$48K ﹤0.01% 3987
2024
Q4 		$184K Hold
40,858
– – ﹤0.01% 4016
2024
Q3 		$113K Sell
40,858
-109,120
-73% -$336K ﹤0.01% 4020
2024
Q2 		$513K Sell
149,978
-18,267
-11% -$83.8K ﹤0.01% 3500
2024
Q1 		$912K Buy
168,245
+121,427
+259% +$872K ﹤0.01% 3351
2023
Q4 		$254K Buy
46,818
+4,892
+12% +$23.1K ﹤0.01% 3801
2023
Q3 		$369K Buy
+41,926
New +$558K ﹤0.01% 3597

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Northern Trust's SGMT Position: Q2 2026 in Review

Northern Trust increased its Sagimet Biosciences (SGMT) stake by 744% in Q2 2026, buying an estimated $2.81M and bringing the position to 468,385 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

Northern Trust first reported a position in SGMT in Q3 2023 and has held it in 12 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Northern Trust held 468,385 shares of Sagimet Biosciences worth $3.62M as of Q2 2026.
  • Northern Trust bought 412,874 Sagimet Biosciences shares in Q2 2026, an estimated $2.81M.
  • Sagimet Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2810 holding.
  • Northern Trust first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 12 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.